Drug intelligence / Profile preview

EF192B

Development stage: Preclinical
Administration: Topical

Overview

EF192B is an experimental topical barrier spray designed for skin protection. Clinical studies are evaluating its ability to form a protective barrier on the skin, with potential efficacy in protecting against small injuries such as cuts, bruises, blisters, cracks, and callus formation. Its development appears to focus on improving skin barrier functions and promoting healing or protection of minor cutaneous lesions[4][5]. The exact composition and mechanism of action are not detailed in public sources.

Beyond the preview

Go deeper on EF192B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EF192B.

Explore the full profile